Citigroup
VMD icon

Citigroup’s Viemed Healthcare VMD Stock Holding History

Citigroup’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$187K Buy
16,417
+14,163
+628% +$140K ﹤0.01% 4381
2026
Q1 		$20.8K Buy
2,254
+944
+72% +$7.86K ﹤0.01% 4808
2025
Q4 		$9.73K Sell
1,310
-1,774
-58% -$12.2K ﹤0.01% 5063
2025
Q3 		$20.9K Sell
3,084
-9,990
-76% -$67.6K ﹤0.01% 4801
2025
Q2 		$90.3K Sell
13,074
-12,846
-50% -$87.2K ﹤0.01% 4456
2025
Q1 		$189K Sell
25,920
-2,067
-7% -$16.2K ﹤0.01% 4235
2024
Q4 		$224K Buy
27,987
+2,738
+11% +$23.8K ﹤0.01% 4349
2024
Q3 		$185K Buy
25,249
+17,234
+215% +$123K ﹤0.01% 4394
2024
Q2 		$52.5K Buy
8,015
+2,024
+34% +$15.3K ﹤0.01% 4549
2024
Q1 		$56.5K Buy
5,991
+883
+17% +$7.57K ﹤0.01% 4564
2023
Q4 		$40.1K Buy
5,108
+5,076
+15,863% +$36.8K ﹤0.01% 4641
2023
Q3 		$216 Sell
32
-10,485
-100% -$85.9K ﹤0.01% 5313
2023
Q2 		$103K Sell
10,517
-56,368
-84% -$572K ﹤0.01% 4237
2023
Q1 		$646K Buy
66,885
+23,043
+53% +$201K ﹤0.01% 2924
2022
Q4 		$332K Buy
43,842
+34,050
+348% +$231K ﹤0.01% 3436
2022
Q3 		$59K Buy
9,792
+9,079
+1,273% +$58.3K ﹤0.01% 4320
2022
Q2 		$4K Sell
713
-1,123
-61% -$6.05K ﹤0.01% 5721
2022
Q1 		$9K Sell
1,836
-7,333
-80% -$34K ﹤0.01% 5597
2021
Q4 		$48K Buy
9,169
+4,913
+115% +$27.4K ﹤0.01% 5091
2021
Q3 		$24K Buy
4,256
+2,572
+153% +$16.7K ﹤0.01% 5159
2021
Q2 		$12K Sell
1,684
-625
-27% -$5.41K ﹤0.01% 5590
2021
Q1 		$23K Sell
2,309
-7,113
-75% -$67K ﹤0.01% 5177
2020
Q4 		$74K Sell
9,422
-24,055
-72% -$212K ﹤0.01% 5770
2020
Q3 		$290K Buy
33,477
+28,805
+617% +$291K ﹤0.01% 4313
2020
Q2 		$45K Buy
+4,672
New +$36.3K ﹤0.01% 6091

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Citigroup's VMD Position: Q2 2026 in Review

Citigroup increased its Viemed Healthcare (VMD) stake by 628% in Q2 2026, buying an estimated $140K and bringing the position to 16,417 shares worth $187K. The position accounts for ﹤0.01% of the portfolio, ranked #4381.

Citigroup first reported a position in VMD in Q2 2020 and has held it in 25 quarters since. The position peaked at $646K in Q1 2023. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Citigroup held 16,417 shares of Viemed Healthcare worth $187K as of Q2 2026.
  • Citigroup bought 14,163 Viemed Healthcare shares in Q2 2026, an estimated $140K.
  • Viemed Healthcare made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4381 holding.
  • Citigroup first reported a position in Viemed Healthcare in Q2 2020 and has held it in 25 quarters since.
  • Citigroup's Viemed Healthcare position peaked at $646K in Q1 2023.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.